Degludec insulin

DRUG4 trials

Sponsors

King Faisal Specialist Hospital & Research Center, Beijing Tsinghua Chang Gung Hospital, Sunshine Lake Pharma Co., Ltd., Max Healthcare Insititute Limited

Conditions

Critical IllnessDiabetes MellitusGlucocorticoid Induced HyperglycemiaHealthy Adult MaleHyperglycemiaType 2 Diabetic Patients

Phase 1

Single-ascending Dose Study of HEC-151 Injection

RecruitingNCT07376200

Sunshine Lake Pharma Co., Ltd.Healthy Adult Male

Start: 2026-02-24End: 2026-09-27Target: 81Updated: 2026-04-29

Phase 4

A Study Comparing Degu Insulin Liraglutide Injection With Premixed Insulin on the Prognosis of Diabetes Mellitus

Enrolling by invitationNCT06925334

Beijing Tsinghua Chang Gung HospitalType 2 Diabetic Patients

Start: 2024-05-20End: 2025-12-31Target: 170Updated: 2025-04-13

Comparing the Safety and Efficacy of Insulin GLARGINE and DEGLUDEC in Glucocorticoid Induced HYPERGLYCEMIA in Hospitalized Patients".

CompletedNCT07599891

Max Healthcare Insititute LimitedGlucocorticoid Induced Hyperglycemia

Start: 2023-09-01End: 2025-03-31Updated: 2026-05-20

Unknown Phase

Degludec Insulin Use in Critically Ill Patients

CompletedNCT06056167

King Faisal Specialist Hospital & Research CenterCritical Illness, Diabetes Mellitus, Hyperglycemia

Start: 2023-05-17End: 2024-05-30Updated: 2024-06-13